clinical trial · NCT07224256
VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
Neuralink Corp·N/A·recruiting·n = 6
Tetraplegia/TetraparesisQuadriplegiaCervical Spinal Cord InjuryAmyotrophic Lateral SclerosisQuadriplegia/TetraplegiaTetraplegic; ParalysisStrokeN1 ImplantR1 Robot
brief summary
The VOICE Study is an early feasibility study to evaluate the initial clinical safety and efficacy of the N1 and R1 Systems device design concept in providing an ability to communicate. The Neuralink N1 Implant is intended to provide the ability to communicate to individuals with severe and irreversible speech production impairment. It is indicated for adults with neurological conditions of the central speech pathways who have impaired upper limb function. The N1 Implant is a skull-mounted, wireless, rechargeable implant connected to electrode threads that are implanted in the brain by the R1 Robot, a robotic electrode thread inserter.
started
Oct 3, 2025
primary completion
Oct 1, 2028
completion
Oct 1, 2031
last updated
Nov 4, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol